Molecular Partners Q3 EPS $(0.38) Beats $(0.46) Estimate

Molecular Partners (NASDAQ:MOLN) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.46) by 17.39 percent. This is a 76.97 percent increase over losses of $(1.65) per share from the same period last year.